When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
NOVN - Ligand nabs economic rights to skin infection candidate from Novan for up to $32M
Novan Inc.
Ligand Pharmaceuticals (LGND+1.1%) has acquired the economic rights to Novan's (NOVN-0.5%) SB206, a topical antiviral gel in Phase 3 development for skin infections, for $12M in upfront cash, up to $20M in milestones and tiered royalties of 7 - 10%.
More news on: Ligand Pharmaceuticals Incorporated, Novan, Inc., Healthcare stocks news, Stocks on the move,